iCAD prices underwritten public offering of 2,400,000 shares of common stock

[News]

iCAD, Inc. ("iCAD"), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy solutions for the early identification and treatment of cancer, today announced it has priced a registered firm commitment underwritten public offering of 2,400,000 shares of its common stock at a price to public of $11.00 per share.

More... (http://www.news-medical.net/news/20140312/iCAD-prices-underwritten-public-offering-of-2400000-shares-of-common-stock.aspx)